Noninvasive Ultrasound Molecular Imaging of the Effect of Statins on Endothelial Inflammatory Phenotype in Early Atherosclerosis

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Khanicheh, Elham ^a   Mitterhuber, Martina ^a   Xu, Lifen ^a   Haeuselmann, Stéphanie P ^a   Kuster, Gabriela M ^a,b   Kaufmann, Beat A ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE DELETION; HEART FUNCTION; HISTOPATHOLOGY; IMMUNOHISTOLOGY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ULTRASOUND; WESTERN BLOTTING;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MICE; MOLECULAR IMAGING; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84875015525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058761     Document Type: Article

References (21)

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of scotland coronary prevention study group. N Engl J Med 333: 1301-1307.
2. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, et al. (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of afcaps/texcaps. Air force/texas coronary atherosclerosis prevention study. JAMA 279: 1615-1622.
3. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial-lipid lowering arm (ascot-lla): A multicentre randomised controlled trial. Lancet 361: 1149-1158.
4. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, et al. (2008) Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 359: 2195-2207.
5. Chyu KY, Shah PK, (2011) Emerging therapies for atherosclerosis prevention and management. Cardiol Clin 29: 123-135.
6. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, et al. (1999) Direct demonstration of p-selectin- and vcam-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein e-deficient mice. Circ Res 84: 1237-1244.
7. Kaufmann BA, Carr CL, Belcik JT, Xie A, Kron B, et al. (2010) Molecular imaging of the initial inflammatory response in atherosclerosis: Implications for early detection of disease. Arterioscler Thromb Vasc Biol 30: 54-59.
8. Powell-Braxton L, Veniant M, Latvala RD, Hirano KI, Won WB, et al. (1998) A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med 4: 934-938.
9. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, et al. (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to p-selectin. Circulation 104: 2107-2112.
10. Foster FS, Zhang MY, Zhou YQ, Liu G, Mehi J, et al. (2002) A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol. 28: 1165-1172.
11. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, et al. (2001) A major role for vcam-1, but not icam-1, in early atherosclerosis. J Clin Invest 107: 1255-1262.
12. Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, et al. (1999) Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85: 199-207.
13. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, et al. (2007) Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 116: 276-284.
14. Bustos C, Hernandez-Presa MA, Ortego M, Tunon J, Diaz C, et al. (1998) Hmg-coa reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 32: 2057-2064.
15. Sukhova GK, Williams JK, Libby P, (2002) Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol 22: 1452-1458.
16. Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, et al. (2001) Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-coa reductase on the expression of vcam-1 and e-selectin in endothelial cells. Biochem J 360: 363-370.
17. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, et al. (2007) Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27: 1706-1721.
18. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, et al. (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114: 1504-1511.
19. Fujimoto S, Hartung D, Ohshima S, Edwards DS, Zhou J, et al. (2008) Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: Resolution with dietary modification and statin therapy. J Am Coll Cardiol 52: 1847-1857.
20. Khanicheh E, Mitterhuber M, Kinslechner K, Xu L, Lindner JR, et al. (2012) Factors affecting the endothelial retention of targeted microbubbles: Influence of microbubble shell design and cell surface projection of the endothelial target molecule. J Am Soc Echocardiogr 25: 460-466.
21. Meuwese MC, Mooij HL, Nieuwdorp M, van Lith B, Marck R, et al. (2009) Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. J Lipid Res 50: 148-153.